Item 5. Other Information
Item
5. Other Information
None.
35
NeuroOne Medical Technologies Corporation
Form 10-Q
Item
6. Exhibits
3.1
Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.4 on the Registrant’s Current Report on Form 8-K filed on June, 29, 2017).
3.2
Certificate of Amendment to Amended and Restated Certificate of Incorporation of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.1 on the Registrant’s Current Report on Form 8-K filed on March 31, 2021).
3.3
Bylaws of NeuroOne Medical Technologies Corporation (incorporated by reference to Exhibit 3.5 on the Registrant’s Current Report on Form 8-K filed on June 29, 2017).
10.1+
Employment Offer Letter, dated as of January 1, 2021, by and between Ron McClurg and the Company (incorporated by reference to Exhibit 10.1 on the Registrant’s Current Report on Form 8-K filed with the SEC on January 7, 2021).
10.2
Form of Warrant (incorporated by reference to Exhibit 4.1 on the Registrant’s Current Report on Form 8-K filed with the SEC on January 15, 2021).
10.3*
Form of Common Stock and Warrant Purchase Agreement (incorporated by reference to Exhibit 10.1 on the Registrant’s Current Report on Form 8-K filed with the SEC on January 15, 2021).
Exhibit
31.1
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit
31.2
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit
32.1
Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit
32.2
Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit
101.INS
XBRL
Instance Document.
Exhibit
101.SCH
XBRL
Taxonomy Extension Schema Document.
Exhibit
101.CAL
XBRL
Taxonomy Extension Calculation Linkbase Document.
Exhibit
101.DEF
XBRL
Taxonomy Extension Definition Linkbase Document.
Exhibit
101.LAB
XBRL
Taxonomy Extension Label Linkbase Document.
Exhibit
101.PRE
XBRL
Taxonomy Extension Presentation Linkbase Document.
+
Indicates management
contract or compensatory plan.
*
Schedules and exhibits
to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish any omitted
schedules or exhibits upon the request of the Securities and Exchange Commission. A list of the omitted schedules and exhibits
to this agreement is as follows: Exhibit A: Schedule of Purchasers; Exhibit B: Form of Warrant; Exhibit C: Selling Stockholder
Questionnaire; and Exhibit D: Form of Lock-Up.
36
NeuroOne Medical Technologies Corporation
Form 10-Q
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf
by the undersigned thereunto duly authorized.
Dated:
May 14, 2021
NeuroOne
Medical Technologies Corporation
By:
/s/ David Rosa
David Rosa
Chief Executive Officer
(Principal Executive Officer)
By:
/s/ Ronald McClurg
Ronald McClurg
Chief Financial Officer
(Principal Financial Officer)
37
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.